Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2018-11-05 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
独立董事关于聘任公司总裁的独立意见
Board/Management Information Classification · 95% confidence The document is a formal independent opinion from the independent directors regarding the appointment of the company's president. It discusses the qualifications, legal compliance, and approval of the appointment. There is no financial data, no report or announcement of financial results, no voting results, and no mention of other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2018-11-05 Chinese
关于回购公司股份的债权人通知公告
Transaction in Own Shares Classification · 95% confidence The document is a notification regarding the company's plan to repurchase its own shares, including details about the repurchase amount, price, period, and impact on the company's financials. It also includes instructions for creditors to submit claims related to this repurchase. The key phrase is '关于回购公司股份的债权人通知公告' which translates to 'Notice to creditors regarding the company's share repurchase.' This is a clear announcement about a share repurchase activity, not a full financial report or earnings release. Therefore, it fits the category of Transaction in Own Shares (POS). The document length is 1721 characters, which is relatively short and consistent with an announcement rather than a detailed report. Hence, the classification is POS with high confidence.
2018-11-02 Chinese
九届一次监事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the supervisory board of Kunming Pharmaceutical Group Co., Ltd. It details the resolutions from the first meeting of the ninth supervisory board, including the election of the supervisory board chairman and appointment of the office director. The content focuses on changes in the company's supervisory board personnel and their roles, with voting results and personal resumes provided. There is no financial data, audit information, or report publication mentioned. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2018-11-02 Chinese
2018年第五次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, attendance, and voting procedures of a specific shareholders' meeting (the 2018 fifth extraordinary general meeting) of Kunming Pharmaceutical Group Co., Ltd. It details the legality and validity of the meeting and the resolutions passed, including board elections and share repurchase proposals. The document does not contain financial statements or results but focuses on the legal compliance and procedural correctness of the shareholders' meeting. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports on the official voting outcomes and shareholder meeting procedures.
2018-11-02 Chinese
关于公司董事何勤先生减持股份结果公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the shareholding activity of a company director, specifically about the non-implementation of a planned share reduction by Mr. He Qin, a director of Kunming Pharmaceutical Group Co., Ltd. It details the shareholding before and after the planned reduction period, confirming no shares were sold. The content focuses on insider share transactions by a company director, which fits the definition of 'Director's Dealing' filings. The document is short and specific to insider share transactions, not a broader financial report or other category.
2018-11-02 Chinese
九届一次董事会决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from Kunming Pharmaceutical Group Co., Ltd. regarding the resolutions passed at the first meeting of the ninth board of directors. It details the election and appointment of key board members and senior management positions such as chairman, vice chairman, president, board secretary, financial director, vice presidents, and securities affairs representative. The document includes personal resumes and voting results for each appointment. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on changes and appointments in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is about 4713 characters, which is consistent with a detailed management announcement rather than a brief notice or report publication announcement.
2018-11-02 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.